Dr. Mary Beth Seegars

Claim this profile

Wake Forest University School of Medicine

Studies Mantle Cell Lymphoma
Studies Lymphoma
1 reported clinical trial
1 drug studied

Affiliated Hospitals

Image of trial facility.
Wake Forest University School Of Medicine

More about Mary Beth Seegars

Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Mary Beth Seegars has experience with
  • LOXO-305
Breakdown of trials Mary Beth Seegars has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mary Beth Seegars specialize in?
Mary Beth Seegars focuses on Mantle Cell Lymphoma and Lymphoma. In particular, much of their work with Mantle Cell Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Mary Beth Seegars currently recruiting for clinical trials?
No, Mary Beth Seegars is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Mary Beth Seegars has studied deeply?
Yes, Mary Beth Seegars has studied treatments such as LOXO-305.
What is the best way to schedule an appointment with Mary Beth Seegars?
Apply for one of the trials that Mary Beth Seegars is conducting.
What is the office address of Mary Beth Seegars?
The office of Mary Beth Seegars is located at: Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.